Our Halo-Lido trial willhave finalpatient byend of 2022Not manycompaniesthis size with2 late stageassetsMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeThere are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityWe will openupinternationalsites forMino-Lok trialInsidersinvested$26.5mHemorrhoidsis a $2BmarketI'm ashareholdermyselfMyron Holubiakand I founded aprivatecompany in2013We expect tofinish theMino-Loktrial this yearI won't diluteshareholdersWe intendto submita BLA in2H 2022Mino-Lokpotentialmarket>$1BAnymentionof Mino-WrapAn actualiMSCupdateI/ONTAK'spotentialmarket is>$300mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Only biotechwith 2 Myron'son theleadershipteamThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We had aphase 2btrial with100%efficacyWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022Not manycompaniesthis size with2 late stageassetsMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeThere are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityWe will openupinternationalsites forMino-Lok trialInsidersinvested$26.5mHemorrhoidsis a $2BmarketI'm ashareholdermyselfMyron Holubiakand I founded aprivatecompany in2013We expect tofinish theMino-Loktrial this yearI won't diluteshareholdersWe intendto submita BLA in2H 2022Mino-Lokpotentialmarket>$1BAnymentionof Mino-WrapAn actualiMSCupdateI/ONTAK'spotentialmarket is>$300mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Only biotechwith 2 Myron'son theleadershipteamThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We had aphase 2btrial with100%efficacyWe haveenough cashto go wellinto 2023I/ONTAKis our leadasset

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Our Halo-Lido trial will have final patient by end of 2022
  2. Not many companies this size with 2 late stage assets
  3. Mino-Lok is our lead asset
  4. I/ONTAK was the best deal I ever made
  5. There are no FDA approved drugs to treat hemorrhoids
  6. We will have exclusivity
  7. We will open up international sites for Mino-Lok trial
  8. Insiders invested $26.5m
  9. Hemorrhoids is a $2B market
  10. I'm a shareholder myself
  11. Myron Holubiak and I founded a private company in 2013
  12. We expect to finish the Mino-Lok trial this year
  13. I won't dilute shareholders
  14. We intend to submit a BLA in 2H 2022
  15. Mino-Lok potential market >$1B
  16. Any mention of Mino-Wrap
  17. An actual iMSC update
  18. I/ONTAK's potential market is >$300m
  19. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  20. Only biotech with 2 Myron's on the leadership team
  21. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  22. We had a phase 2b trial with 100% efficacy
  23. We have enough cash to go well into 2023
  24. I/ONTAK is our lead asset